Publications by authors named "C L Morton"

Background: Patients with diffuse anaplastic Wilms tumor (DAWT) experience relatively poor oncologic outcomes. Previous work has described mechanisms of telomerase upregulation in DAWT, posing a potential therapeutic target.

Methods: We assessed in vitro sensitivity to vincristine, irinotecan, and telomerase-targeting drug 6-thio-2'-deoxyguanosine (6 dG) in DAWT cell lines WiT49 and PDM115 and in spheroids derived from cell lines and four DAWT patient-derived xenografts (PDX).

View Article and Find Full Text PDF
Article Synopsis
  • Newborn hearing screening is crucial for identifying infants who may be deaf or hard of hearing (DHH), but it can sometimes miss mild or later-onset cases.
  • Advances in genomic technologies offer better diagnosis for DHH in infants who don’t pass initial screenings, highlighting a potential need for comprehensive genomic screening for all newborns.
  • This shift towards genomic testing aims to improve the early detection of genetic causes of hearing loss, ultimately aiding long-term development in affected children.
View Article and Find Full Text PDF

As structural biology and drug discovery depend on high-quality protein structures, assessment tools are essential. We describe a new method for validating amino-acid conformations: "PhiSiCal ([Formula: see text]al) Checkup." Twenty new joint probability distributions in the form of statistical mixture models explain the empirical distributions of dihedral angles [Formula: see text] of canonical amino acids in experimental protein structures.

View Article and Find Full Text PDF

Datasets are often considered "ideal" when they are large and contain longitudinal and representative data. But even research that uses ideal datasets might not generate high-quality evidence. This article emphasizes the roles that transparency plays in enhancing observational epidemiological findings' credibility and relevance and argues that epidemiological research can produce high-quality evidence even when datasets are not ideal.

View Article and Find Full Text PDF

In silico trials for drug safety assessment require many high-fidelity 3D cardiac simulations to predict drug-induced QT interval prolongation, which is often computationally prohibitive. To streamline this process, we developed sex-specific emulators for a fast prediction of QT interval, trained on a dataset of 900 simulations. Our results show significant differences between 3D and 0D single-cell models as risk levels increase, underscoring the ability of 3D modeling to capture more complex cardiac responses.

View Article and Find Full Text PDF